---
title: Future direction of total neoadjuvant therapy for locally advanced rectal cancer
date: '2024-03-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38485756/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240315180616&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Despite therapeutic advancements, disease-free survival and overall survival
  of patients with locally advanced rectal cancer have not improved in most trials
  as a result of distant metastases. For treatment decision-making, both long-term
  oncologic outcomes and impact on quality-of-life indices should be considered (for
  example, bowel function). Total neoadjuvant therapy (TNT), comprised of chemotherapy
  and radiotherapy or chemoradiotherapy, is now a standard treatment approach in patients
  ...
disable_comments: true
---
Despite therapeutic advancements, disease-free survival and overall survival of patients with locally advanced rectal cancer have not improved in most trials as a result of distant metastases. For treatment decision-making, both long-term oncologic outcomes and impact on quality-of-life indices should be considered (for example, bowel function). Total neoadjuvant therapy (TNT), comprised of chemotherapy and radiotherapy or chemoradiotherapy, is now a standard treatment approach in patients ...